Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
Deirdre K. Tobias,Jordi Merino,Abrar Ahmad,Catherine Aiken,Jamie L. Benham,Dhanasekaran Bodhini,Amy L. Clark,Kevin Colclough,Rosa Corcoy,Sara J. Cromer,Daisy Duan,Jamie L. Felton,Ellen C. Francis,Pieter Gillard,Véronique Gingras,Romy Gaillard,Eram Haider,Alice Hughes,Jennifer M. Ikle,Laura M. Jacobsen,Anna R. Kahkoska,Jarno L. T. Kettunen,Raymond J. Kreienkamp,Lee-Ling Lim,Jonna M. E. Männistö,Robert Massey,Niamh-Maire Mclennan,Rachel G. Miller,Mario Luca Morieri,Jasper Most,Rochelle N. Naylor,Bige Ozkan,Kashyap Amratlal Patel,Scott J. Pilla,Katsiaryna Prystupa,Sridharan Raghavan,Mary R. Rooney,Martin Schön,Zhila Semnani-Azad,Magdalena Sevilla-Gonzalez,Pernille Svalastoga,Wubet Worku Takele,Claudia Ha-ting Tam,Anne Cathrine B. Thuesen,Mustafa Tosur,Amelia S. Wallace,Caroline C. Wang,Jessie J. Wong,Jennifer M. Yamamoto,Katherine Young,Chloé Amouyal,Mette K. Andersen,Maxine P. Bonham,Mingling Chen,Feifei Cheng,Tinashe Chikowore,Sian C. Chivers,Christoffer Clemmensen,Dana Dabelea,Adem Y. Dawed,Aaron J. Deutsch,Laura T. Dickens,Linda A. DiMeglio,Monika Dudenhöffer-Pfeifer,Carmella Evans-Molina,María Mercè Fernández-Balsells,Hugo Fitipaldi,Stephanie L. Fitzpatrick,Stephen E. Gitelman,Mark O. Goodarzi,Jessica A. Grieger,Marta Guasch-Ferré,Nahal Habibi,Torben Hansen,Chuiguo Huang,Arianna Harris-Kawano,Heba M. Ismail,Benjamin Hoag,Randi K. Johnson,Angus G. Jones,Robert W. Koivula,Aaron Leong,Gloria K. W. Leung,Ingrid M. Libman,Kai Liu,S. Alice Long,William L. Lowe,Robert W. Morton,Ayesha A. Motala,Suna Onengut-Gumuscu,James S. Pankow,Maleesa Pathirana,Sofia Pazmino,Dianna Perez,John R. Petrie,Camille E. Powe,Alejandra Quinteros,Rashmi Jain,Debashree Ray,Mathias Ried-Larsen,Zeb Saeed,Vanessa Santhakumar,Sarah Kanbour,Sudipa Sarkar,Gabriela S. F. Monaco,Denise M. Scholtens,Elizabeth Selvin,Wayne Huey-Herng Sheu,Cate Speake,Maggie A. Stanislawski,Nele Steenackers,Andrea K. Steck,Norbert Stefan,Julie Støy,Rachael Taylor,Sok Cin Tye,Gebresilasea Gendisha Ukke,Marzhan Urazbayeva,Bart Van der Schueren,Camille Vatier,John M. Wentworth,Wesley Hannah,Sara L. White,Gechang Yu,Yingchai Zhang,Shao J. Zhou,Jacques Beltrand,Michel Polak,Ingvild Aukrust,Elisa de Franco,Sarah E. Flanagan,Kristin A. Maloney,Andrew McGovern,Janne Molnes,Mariam Nakabuye,Pål Rasmus Njølstad,Hugo Pomares-Millan,Michele Provenzano,Cécile Saint-Martin,Cuilin Zhang,Yeyi Zhu,Sungyoung Auh,Russell de Souza,Andrea J. Fawcett,Chandra Gruber,Eskedar Getie Mekonnen,Emily Mixter,Diana Sherifali,Robert H. Eckel,John J. Nolan,Louis H. Philipson,Rebecca J. Brown,Liana K. Billings,Kristen Boyle,Tina Costacou,John M. Dennis,Jose C. Florez,Anna L. Gloyn,Maria F. Gomez,Peter A. Gottlieb,Siri Atma W. Greeley,Kurt Griffin,Andrew T. Hattersley,Irl B. Hirsch,Marie-France Hivert,Korey K. Hood,Jami L. Josefson,Soo Heon Kwak,Lori M. Laffel,Siew S. Lim,Ruth J. F. Loos,Ronald C. W. Ma,Chantal Mathieu,Nestoras Mathioudakis,James B. Meigs,Shivani Misra,Viswanathan Mohan,Rinki Murphy,Richard Oram,Katharine R. Owen,Susan E. Ozanne,Ewan R. Pearson,Wei Perng,Toni I. Pollin,Rodica Pop-Busui,Richard E. Pratley,Leanne M. Redman,Maria J. Redondo,Rebecca M. Reynolds,Robert K. Semple,Jennifer L. Sherr,Emily K. Sims,Arianne Sweeting,Tiinamaija Tuomi,Miriam S. Udler,Kimberly K. Vesco,Tina Vilsbøll,Robert Wagner,Stephen S. Rich,Paul W. Franks,William L. Lowe Jr
DOI: https://doi.org/10.1038/s41591-023-02502-5
IF: 82.9
2023-10-05
Nature Medicine
Abstract:Precision medicine is part of the logical evolution of contemporary evidence-based medicine that seeks to reduce errors and optimize outcomes when making medical decisions and health recommendations. Diabetes affects hundreds of millions of people worldwide, many of whom will develop life-threatening complications and die prematurely. Precision medicine can potentially address this enormous problem by accounting for heterogeneity in the etiology, clinical presentation and pathogenesis of common forms of diabetes and risks of complications. This second international consensus report on precision diabetes medicine summarizes the findings from a systematic evidence review across the key pillars of precision medicine (prevention, diagnosis, treatment, prognosis) in four recognized forms of diabetes (monogenic, gestational, type 1, type 2). These reviews address key questions about the translation of precision medicine research into practice. Although not complete, owing to the vast literature on this topic, they revealed opportunities for the immediate or near-term clinical implementation of precision diabetes medicine; furthermore, we expose important gaps in knowledge, focusing on the need to obtain new clinically relevant evidence. Gaps include the need for common standards for clinical readiness, including consideration of cost-effectiveness, health equity, predictive accuracy, liability and accessibility. Key milestones are outlined for the broad clinical implementation of precision diabetes medicine.
biochemistry & molecular biology,cell biology,medicine, research & experimental